The ERS Tobacco Control Committee coordinates the European Respiratory Society’s (ERS) activities on tobacco control at every level.
The committee works with professionals who are on the frontline in hospitals, clinics and universities; at the European level, with an office to monitor tobacco control; and at the international level through global conferences and membership of organisations such as the Framework Convention Alliance.
The committee has developed strong partnerships with cancer and heart organisations and encouraged a strict code of conduct for relations with the tobacco industry for ERS members.
| Company | Area | Product | Amount of funds received* |
|---|---|---|---|
| Astra zeneca | Advisory Board | future plans | A |
| GSK | Advisory Board | future plans | A |
| Novartis | Advisory Board | plans | A |
| Sandoz | Invited speaker | presentation | A |
| Chiesi | Invited speaker&Ad.Board | presentation | A |
| DEVA | Invited speaker&Ad.Board | presentation | A |
| Abdi İbrahim | Invited speaker&Ad.Board | presentation | A |
None
None
None
| Company | Nature of Support | Amount of funds received* |
|---|---|---|
| MSD | Clinical Research | B |
| Sanofi | Clinical Research | B |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
None
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
| A | B | C | D |
|---|---|---|---|
| less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
ERS Executive Director is an observer.
